Member Info for Timster

Sounds good

But as has been said the market is huge the focus isn't just the UK it's the WORLD

Yeah the government are the shisters not avacta :)

I'd imagine at this stage avacta must have opened a dialog with the government! Although they are a bunch of useless shisters so they probably haven't

maybe thats why its rising Avacta also have an affirmer for that :)

that sweet guy was right ;-)

to be fair anyone can say RNS tomorrow and there is a chance they'd be right.

But I reckon their will be too

those yanks will be all over MedUSA a whooping and a hollering!

I asked this last night but it got lost, it'll probably get lost again but here we go :
Ive not held shares in a pharma before. For those experienced in such things are they likely to RNS the test has been manufactured and tested. Then RNS when it starts it's approval testing, then RNS the result of the approval process?

Or just RNS once approved?

I've said this before and not really got an answer, are they just balancing the books at the end of the day and not "real" trades?

Boring! for your own piece of mind I'd take your concerns to the FCA or call the police

Not confirmed pure speculation could be in any cytiva lab around the world

I'm just up the road I'll go and sneak a look through the window :)

I'm just up the road I'll go and sneak a look through the window :)

Ive not held shares in a pharma before. For those experienced in such things are they likely to RNS the test has been manufactured and tested. Then RNS when it starts it's approval testing, then RNS the result of the approval process?

Or just RNS once approved?

It's not boohoo it's medusa19 conceived by the creator billionaires of boohoo who know a little about worldwide distribution network's

but the yanks arrive at 1.30 and nothing happened then

or MEDical USA to make trump think its American ;)

always always get sellers into an RNS always doesn't matter how good you think it is there are always people who sell when an RNS is published

have you read the RNS? any approval will be subject of another RNS then you'd hope the price will go through the roof:

The significant investment that Medusa19 is making in conjunction with the track records of the Medusa19 team, gives me great confidence in the rapid growth of direct-to-consumer sales of the Avacta COVID-19 test across the United Kingdom, European Union and the United States SUBJECT TO THE NECESSARY REGULATORY APPROVALS. I expect the commercial impact of this partnership to be very significant to Avacta.

its a stupid myth...:)